Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients.
Parrish
A G
AG
D000328:Adult; D002439:Cefotaxime / Q000191:economics / Q000627:therapeutic use; D002443:Ceftriaxone / Q000191:economics* / Q000627:therapeutic use*; D002511:Cephalosporins / Q000191:economics* / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D006801:Humans; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D016896:Treatment Outcome
D002511:Cephalosporins; D002443:Ceftriaxone; D002439:Cefotaxime